NEW YORK (GenomeWeb News) – Knome has made several new additions to its management team and scientific advisory board.
Martin Tolar will become the firm's CEO, replacing Jorge Conde, who will become chief strategy officer and continue to serve on the board of directors. Previously, Tolar served as CEO of Normoxys, where he helped advance the company's cancer therapeutics to clinical development. He has also served as chief scientific officer and chief business officer at CoMentis, and has held a variety of positions at Pfizer in its clinical development, strategic partnerships, and business development divisions.
Jonas Lee, a founding member of Knome's board of directors, will become chief marketing officer and head of consumer genomics. Previously, he founded and managed several companies including Redbrick Partners, Poindexter Systems, GiftCertificates.com, and Integrated Computing Engines. He has also served as a management consult with Bain & Company.
Marc Rubenfield will become the vice president of operations. Prior to joining Knome, he was responsible for the sequencing services product line, including the introduction of next-generation sequencing, at Beckman Coulter Genomics. He has also worked at Agencourt Biosciences and Genome Therapeutics.
Knome also has appointed David Goldstein and Yaniv Erlich to its scientific advisory board.
Goldstein is a professor of molecular genetics and microbiology, a professor of biology, and director of the Center for Human Genome Variation at Duke University. He is also an honorary professor at the Institute of Neurology at the University College London. Previously he was a professor of genetics at University College London.
Erlich is a principal investigator at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology.
Three new members have been appointed to the National Advisory Council for Biomedical Imaging and Bioengineering of the National Institute of Biomedical Imaging and Bioengineering.
The new members include: John Gore, director of the Institute of Imaging Science and a professor at Vanderbilt University Medical Center; Cato Laurencin, director of the Institute for Regenerative Engineering, CEO of the Connecticut Institute for Clinical and Translational Science, and a professor at the University of Connecticut; and Mark Musen, head of the Stanford Center for Biomedical Informatics Research and professor of medicine and computer science at Stanford University.
University of Illinois entomologist and neuroscientist Gene Robinson has been appointed director of the university's Institute for Genomic Biology.
Robinson has headed the institute on an interim basis since March. He formerly was leader of the IGB's Genomics of Neural and Behavioral Plasticity lab.
Almac Group has promoted Kevin Stevens to be financial director. He will be responsible for all financial aspects of Almac Group's global activities, leading the financial management teams, supporting the growth of the business, and coordinating financial control. Stevens has been with the company since 2001 and he was appointed position of Almac UK Group financial controller in 2007.
Cedars-Sinai Medical Center has named Robert Baloh to be director of its Neuromuscular Division. Baloh, who most recently was an assistant professor of neurology at Washington University School of Medicine in St. Louis, is a research scientist who has focused on the genetics and molecular biology of amyotrophic lateral sclerosis.
BG Medicine has appointed Eric Bouvier to be its new CEO and a member of its board of directors. He will take over the post for Pieter Muntendam, who after six years as CEO will continue with the company as executive VP and chief medical officer.
Bouvier formerly was head of the immunoassay business and global human resources at BioMerieux and served as president and CEO of BioMerieux Inc. in the US.
Horizon Discovery has appointed Simon Cook to be a non-executive director. Cook currently is CEO of DFJ Esprit and he has worked in venture capital since 1995.
The University of Chicago Medical Center said this week that it has hired Yusuke Nakamura, former director of the Riken Center for Genomic Medicine, to join its faculty.
Nakamura, who currently is secretary general in the Japanese Government's Office of Medical Innovation and a professor of molecular medicine at Tokyo University's Human Genome Center, will join the U of Chicago faculty in April. The school said it recruited Nakamura to continue his research in anticancer drug discovery and development, genomics, and pharmacogenomics.
Biocartis has named Clark Harrison as its new chief operating officer. Harrison formerly was VP of global operations for Leica Biosystems, part of Danaher, and he spent 20 years in the medical device and automotive manufacturing industry.
GeneThera said this week that it has appointed Tony Milici as interim president of Applied Genetics, a joint venture between Nutricion Avanzada and GeneThera.
Located in Monterrey, Mexico, Applied Genetics focuses on molecular testing for Johne's disease, a global and incurable disease of dairy cows, sheep, and goats. The company markets HerdCheck, a proprietary molecular diagnostic test for the disease based on the use of high-throughput robotics and real-time PCR.
Jay Boniface has been appointed as VP of research and development at Sera Prognostics, where he will lead the discovery, translation, and development activities for Sera's preterm birth predictor and other maternal-fetal medicine products.
Boniface previously was scientist and program director at several biotechnology companies, including Myriad Genetics, Myrexis, Prolexys Pharmaceuticals, and Eos Biotechnology.
Agendia has named Peter Wulff as vice president of finance and chief financial officer. Wulff has more than 25 years of experience with financial management and corporate governance in the life sciences industry, the Dutch molecular diagnostics firm said. He is also a certified management accountant. Wulff, who is originally from the Netherlands, will split his time between Agendia's locations in Amsterdam and Irvine, Calif., the firm said.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.